# OnCo record rejuv-paed-late-mortality (technology). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/technologies/rejuv-paed-late-mortality/>
  a schema:MedicalTherapy ;
  onco:kind "technology" ;
  schema:identifier "rejuv-paed-late-mortality" ;
  schema:name "Late deaths after childhood cancer, what causes them, and the proof that gentler treatment worked"@en ;
  schema:description "Five-year survivors still die earlier than their peers, but much less than they did. Fifteen-year mortality among American five-year survivors fell from 12.4 per cent for children treated in the early 1970s to 6.0 per cent for those treated in the 1990s, and the fall tracks the radiotherapy and anthracycline that were taken out of the protocols."@en ;
  schema:url <https://onco.cc/technologies/rejuv-paed-late-mortality/> ;
  schema:dateModified "2026-10-02"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Cancer_survival_rates> ;
  schema:citation <https://doi.org/10.1056/NEJMoa1510795>, <https://doi.org/10.1001/jama.2010.923>, <https://doi.org/10.1136/bmj.i4351>, <https://doi.org/10.1200/JCO.2009.22.3339> ;
  onco:status "established" ;
  onco:tag "rejuvenation", "survivorship", "paediatric", "late-effects", "evidence:strong" ;
  onco:related <https://onco.cc/trials/ccss/>, <https://onco.cc/collections/bccss/>, <https://onco.cc/roadmaps/paediatric-oncology-roadmap/>, <https://onco.cc/roadmaps/survivorship-roadmap/> ;
  onco:cancers <https://onco.cc/cancers/childhood-cancers/>, <https://onco.cc/cancers/all-leukemia/>, <https://onco.cc/cancers/hodgkin-lymphoma/>, <https://onco.cc/cancers/wilms-tumor/>, <https://onco.cc/cancers/medulloblastoma/> ;
  onco:sections <https://onco.cc/fronts/rejuvenation/>, <https://onco.cc/fronts/supportive-care/> ;
  onco:technologies <https://onco.cc/technologies/rejuv-paed-chronic-disease-burden/>, <https://onco.cc/technologies/rejuv-paed-second-cancers/>, <https://onco.cc/technologies/rejuv-paed-heart/>, <https://onco.cc/technologies/survivorship-care-plan/>, <https://onco.cc/terms/radiotherapy/>, <https://onco.cc/technologies/proton-therapy/> ;
  onco:drugs <https://onco.cc/drugs/doxorubicin/>, <https://onco.cc/drugs/cyclophosphamide/> ;
  onco:terms <https://onco.cc/terms/late-effects/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-survivorship/> .